National General · 10 hours ago
Auto Estimator - Supplement Writer - National General
National General is a part of The Allstate Corporation, which focuses on innovative insurance solutions. The Auto Estimator specializing in supplements will be responsible for creating and auditing damage estimates for material damage claims, and will work closely with body shops to negotiate auto estimates and supplements.
FinanceFinancial ServicesInsurance
Responsibilities
Possesses strong estimating fundamentals in order to create or audit estimates of damages on 1st and 3rd party material damage losses of all severities
Possesses a deep understanding of the content of all policy types written by the company
Negotiates settlements, makes settlement payments and documents all activities in the most complex of files across multiple lines
Evaluates settlement alternatives by reviewing regulatory compliance and fair claims practices; makes decisions on best option
Builds mastered relationships with both internal and external customers across multiple lines
Qualification
Required
Strong technical estimating expertise
Deep understanding of repair procedures
Confident negotiation skills when working with repair facilities
Experience writing estimates in CCC
Proficiency with Microsoft applications
Strong estimating fundamentals in order to create or audit estimates of damages on 1st and 3rd party material damage losses of all severities
Deep understanding of the content of all policy types written by the company
Negotiates settlements, makes settlement payments and documents all activities in the most complex of files across multiple lines
Evaluates settlement alternatives by reviewing regulatory compliance and fair claims practices; makes decisions on best option
Builds mastered relationships with both internal and external customers across multiple lines
Preferred
2 or more years of experience
Company
National General
As part of the Allstate family of companies, National General, an Allstate company, is one of the largest insurers in the United States.
Funding
Current Stage
Late StageTotal Funding
$189.99M2020-07-07Acquired
2014-02-21Undisclosed· $189.99M
Recent News
2025-08-04
Research and Markets
2025-06-26
Company data provided by crunchbase